Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ally Bridge Group
Biotech
BioMarin hires ex-Roche leader Hubbard as CCO—Chutes & Ladders
BioMarin names Hubbard as new CCO. Marett is retiring from BioNTech. GSK plucks Flagship partner as new SVP of research technologies.
Max Bayer
,
Gabrielle Masson
Mar 8, 2024 9:30am
CMR Surgical sews up $165M in new funding
Sep 20, 2023 10:09am
Endeavor nabs $101M for IPF, cancer trials—and asset shopping
Feb 7, 2022 8:00am
Feng Zhang's Arbor Bio snags $215M for liver, CNS diseases
Nov 9, 2021 7:00am
Elligo’s $135M fuels acquisition to expand digital R&D platforms
Sep 27, 2021 11:49am
CMR Surgical amasses £425M to take robotic surgery global
Jun 28, 2021 2:00am
